Skip to content

Feasibility Trial of a Mindfulness Based Intervention in Youth With Type 1 Diabetes

Feasibility Trial of a Mindfulness Based Intervention in Youth With Type 1

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05268393
Acronym
BREATHE-T1D
Enrollment
42
Registered
2022-03-07
Start date
2022-03-31
Completion date
2023-07-31
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type1diabetes

Brief summary

Type 1 diabetes (T1D) is one of the most common chronic illnesses of childhood. The involved treatment regimen, including daily insulin administration/pump management, frequent blood glucose checks, and careful track-ing of food intake, places a high-stress burden on patients and their families. Adolescence is a particularly risky time for T1D management given a marked decline in treatment adherence and glycemic control. Over 80% of adolescents with T1D have poor glycemic control (A1c \>7.5%), and one significant risk factor is the increase in negative affectivity, including depression and anxiety symptoms, that distinguish adolescents with T1D. Elevated depression and anxiety symptoms affect 40% of teens with T1D. Preliminary data support the notion that negative affectivity contributes to diminished treatment adherence and worsening of glycemic control, partially through the effects of negative affectivity on stress-related behavior such as maladaptive eating behavior (e.g., dietary restriction, uncontrolled eating patterns, and insulin omission for weight control). There is no gold-standard approach to address the poor glycemic control seen in adolescents with T1D. The creation of novel, targeted interventions, tailored for the developmental needs of adolescents with T1D and the particular burdens of coping with their chronic illness, are needed. Mindfulness-based interventions delivered to adolescents without T1D, including the team's preliminary work in teens with depression and weight-related disorders, have shown promise in treating negative affectivity, maladaptive eating behavior, and health outcomes. A mindfulness-based approach may be well-suited for adolescents with T1D, but given that the mechanisms of association among negative affectivity, stress-related behavior, and self-care are unique to individuals with T1D, interventions must be specifically tailored for this population. The goal of this study is to, therefore, adapt an existing 6-session mindfulness-based intervention, Learning to BREATHE, for use with adolescents with T1D (BREATHE-T1D). The first specific aim of the study is to adapt BREATHE for adolescents with T1D and to adapt a relevant and credible health education comparison curriculum (HealthEd-T1D). The second aim is to carry out a 2-way pilot randomized controlled trial to evaluate the feasibility and acceptability of BREATHE-T1D and HealthEd-T1D. The result of the current study will be a feasible and acceptable mindfulness intervention and comparison curriculum that can be evaluated in an efficacy trial. The multidisciplinary study team contributes complementary areas of expertise in adolescents with T1D, behavioral intervention development, negative affectivity and maladaptive eating behavior, adolescent mindfulness-based intervention, qualitative data analysis, and delivery of behavioral health interventions via telehealth. The study's innovative approach will enable the investigators to establish a feasible/acceptable intervention tailored for adolescents with T1D, leading to a future proposal for a full-scale efficacy trial.

Interventions

BEHAVIORALBREATHE-T1D

BREATHE-T1D is a mindfulness based intervention adapted from Learning to BREATHE specifically for teens with type 1 diabetes.

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Children's National Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* age 12-17y * T1D, with at least 1-year duration of illness * negative affectivity, defined as clinically elevated scores (T-score \>55 indicating at least mild depression/anxiety symptoms on either the PROMIS short form-depression and/or anxiety scales) * A1c \>7.5% * English-speaking

Exclusion criteria

* no cognitive or developmental delays which would interfere with their ability to participate in the study * are able and willing to complete questionnaires and intervention via the internet * do not have severe depression or active or recent (within the past two months) suicidal ideation * have no other serious medical conditions (e.g., cystic fibrosis, cancer).

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Enrolled of Eligible Participants ScreenedDuring screening (10 months total)The percentage is calculated first by identifying the number of enrolled participants divided by eligible participants. 42 total patients were eligible once screened across the 10 month enrollment period. 42 total then enrolled in the study.
Number of Weeks to Enroll Participants to Form One CohortDuring screening (10 months)Number of weeks to enroll 10 participants to be randomized 5 per group
Percentage of Participants With Data CollectedBaseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)Number of participants with data at each time point.
Percentage of Attended SessionsImmediate post-intervention follow-up (2-3 months post baseline)Number of intervention sessions (calculated by multiplying number of expected sessions by number of participants for total possible sessions held) attended divided by total number of intervention sessions expected per group.
Satisfaction With Intervention ProgramImmediate post-intervention follow-up (2-3 months post-baseline)Satisfaction report by participants

Secondary

MeasureTime frameDescription
UPPS-P Negative Urgency SubscaleBaseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)Teen report on the UPPS-P Negative Urgency subscale with higher scores indicating more likelihood to act impulsively when experiencing a negative mood. Scores are calculated with an average which can range from 1(minimum) to 4 (maximum).
Self-Care InventoryBaseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)Teen report on the Self-Care Inventory, a measure of diabetes management with higher scores indicating better self-care for diabetes. Average scores range from 1 (minimum) to 5 (maximum).
Mindful Attention Awareness ScaleBaseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)Assessed via teen report. Scores are calculated as an average score of all items with a range of 1 (minimum) to 6 (maximum) with higher scores indicating more mindful attention in daily life.
Glycemic ControlBaseline, immediate post intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post baseline)HbA1c is a measure of an average blood glucose level over the past 3 months and will be abstracted from the medical record as it is assessed at each regular diabetes clinic visit. HbA1c typically ranges from 4% to \>14%.
Interventionist Adherence to Session ManualsWeek 6 of interventionSupervisors listened to recordings of sessions for both programs and completed checklists assessing for the number of expected intervention components included in the sessions. Therefore, values reflect the percentage of expected intervention components included across all program sessions calculated at the end of the intervention period (week 6) for each group cohort.
Problem Areas in Diabetes - TeenBaseline, immediate post intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)The Problem Areas in Diabetes-Teen (PAID-T) is a 14-item measure of diabetes distress in adolescents with type 1 diabetes. Adolescents are asked how often each diabetes-related problem applied to them in the past month, on a six-point Likert scale (ranging from not a problem to serious problem), with scores reflecting a total across 14 items and higher scores indicating greater severity and a clinical cutoff of \>44. Scores can range from 14-84.
Five-Facet Mindfulness QuestionnaireBaseline, Immediate post-intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post-baseline)Assessed via teen report. Scores are calculated as a total score across all items in the scale with a range of 1 (minimum) to 5 (maximum) and total scores presented are a sum of the sub scale (observing, describing, acting with awareness, nonjudging, and non-reactivity) with possible scores ranging from 5-25 with higher scores indicating more mindfulness.
PROMIS Depression Short Form - Adolescent ReportBaseline, Immediate post-intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post baseline)Scores are calculated as t-scores with higher scores indicating more depressive symptoms. T-scores (range 0-100) over 55 indicate clinically significant depressive symptoms. Interpretation of t-scores is based on a mean of 50 and standard deviation of 10.
PROMIS Anxiety Short Form - Adolescent ReportBaseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)Scores are calculated as t-scores (range 0-100) with higher scores indicating more anxiety symptoms.T-scores over 55 indicate clinically significant anxiety symptoms. Interpretation of t-scores is based on a mean of 50 and standard deviation of 10.
Diabetes Eating Problems Survey RevisedBaseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)Teen report with higher scores indicating more disordered eating behaviors with scores over 25 indicating clinically significant problems. Total scores range from 0 to 64 with higher scores indicating more disordered eating behaviors.

Countries

United States

Participant flow

Participants by arm

ArmCount
BREATHE-T1D
BREATHE-T1D is a 6-week group mindfulness program adapted specifically for teens with type 1 diabetes. BREATHE-T1D: BREATHE-T1D is a mindfulness based intervention adapted from Learning to BREATHE specifically for teens with type 1 diabetes.
20
BREATHE-T1D Health Education
The health education placebo comparator is a 6-week group diabetes-specific education program designed to be informational but not supportive. BREATHE-T1D: BREATHE-T1D is a mindfulness based intervention adapted from Learning to BREATHE specifically for teens with type 1 diabetes.
22
Total42

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject21

Baseline characteristics

CharacteristicBREATHE-T1DTotalBREATHE-T1D Health Education
Age, Continuous14.9 years
STANDARD_DEVIATION 1.8
14.8 years
STANDARD_DEVIATION 1.8
14.7 years
STANDARD_DEVIATION 1.9
Anxiety58.8 T-score
STANDARD_DEVIATION 7.9
57.6 T-score
STANDARD_DEVIATION 7.6
57.1 T-score
STANDARD_DEVIATION 7.2
Depression58.5 T-score
STANDARD_DEVIATION 9
56.7 T-score
STANDARD_DEVIATION 8.6
56.2 T-score
STANDARD_DEVIATION 8.7
Diabetes Distress61.7 units on a scale
STANDARD_DEVIATION 23.5
60.9 units on a scale
STANDARD_DEVIATION 22.4
60.1 units on a scale
STANDARD_DEVIATION 21.9
Disordered Eating21.8 units on a scale
STANDARD_DEVIATION 11.1
22.6 units on a scale
STANDARD_DEVIATION 13.3
23.4 units on a scale
STANDARD_DEVIATION 15.3
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants5 Participants4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
19 Participants37 Participants18 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
HbA1c7.7 percentage
STANDARD_DEVIATION 1.1
8.2 percentage
STANDARD_DEVIATION 2
8.7 percentage
STANDARD_DEVIATION 2.5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
5 Participants11 Participants6 Participants
Race (NIH/OMB)
More than one race
4 Participants10 Participants6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
10 Participants19 Participants9 Participants
Region of Enrollment
United States
20 participants42 participants22 participants
Sex: Female, Male
Female
13 Participants28 Participants15 Participants
Sex: Female, Male
Male
7 Participants14 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 180 / 21
other
Total, other adverse events
0 / 180 / 21
serious
Total, serious adverse events
0 / 180 / 21

Outcome results

Primary

Number of Weeks to Enroll Participants to Form One Cohort

Number of weeks to enroll 10 participants to be randomized 5 per group

Time frame: During screening (10 months)

Population: All randomized participants

ArmMeasureValue (MEAN)
All ParticipantsNumber of Weeks to Enroll Participants to Form One Cohort8 weeks
Primary

Percentage of Attended Sessions

Number of intervention sessions (calculated by multiplying number of expected sessions by number of participants for total possible sessions held) attended divided by total number of intervention sessions expected per group.

Time frame: Immediate post-intervention follow-up (2-3 months post baseline)

Population: The aim was for each participant to attend 6 program sessions. Therefore, the number of expected sessions multiplied by the number of participants are reflected in the overall number of units analyzed.

ArmMeasureValue (NUMBER)
All ParticipantsPercentage of Attended Sessions99 percentage of sessions attended overall
BREATHE-T1D Health EducationPercentage of Attended Sessions100 percentage of sessions attended overall
Primary

Percentage of Enrolled of Eligible Participants Screened

The percentage is calculated first by identifying the number of enrolled participants divided by eligible participants. 42 total patients were eligible once screened across the 10 month enrollment period. 42 total then enrolled in the study.

Time frame: During screening (10 months total)

Population: Number of participants screened (42 in all across 10 months were eligible for the study following screening).

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
All ParticipantsPercentage of Enrolled of Eligible Participants Screened42 Participants
Primary

Percentage of Participants With Data Collected

Number of participants with data at each time point.

Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
All ParticipantsPercentage of Participants With Data CollectedImmediate follow up18 Participants
All ParticipantsPercentage of Participants With Data Collected3 month follow up18 Participants
BREATHE-T1D Health EducationPercentage of Participants With Data Collected3 month follow up21 Participants
BREATHE-T1D Health EducationPercentage of Participants With Data CollectedImmediate follow up21 Participants
Primary

Satisfaction With Intervention Program

Satisfaction report by participants

Time frame: Immediate post-intervention follow-up (2-3 months post-baseline)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
All ParticipantsSatisfaction With Intervention Program15 Participants
BREATHE-T1D Health EducationSatisfaction With Intervention Program19 Participants
Secondary

Diabetes Eating Problems Survey Revised

Teen report with higher scores indicating more disordered eating behaviors with scores over 25 indicating clinically significant problems. Total scores range from 0 to 64 with higher scores indicating more disordered eating behaviors.

Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsDiabetes Eating Problems Survey RevisedImmediate follow up18.6 score on a scaleStandard Deviation 13.1
All ParticipantsDiabetes Eating Problems Survey Revised3 month follow up19.3 score on a scaleStandard Deviation 13.1
BREATHE-T1D Health EducationDiabetes Eating Problems Survey RevisedImmediate follow up18.2 score on a scaleStandard Deviation 14.2
BREATHE-T1D Health EducationDiabetes Eating Problems Survey Revised3 month follow up20.0 score on a scaleStandard Deviation 16.5
Secondary

Five-Facet Mindfulness Questionnaire

Assessed via teen report. Scores are calculated as a total score across all items in the scale with a range of 1 (minimum) to 5 (maximum) and total scores presented are a sum of the sub scale (observing, describing, acting with awareness, nonjudging, and non-reactivity) with possible scores ranging from 5-25 with higher scores indicating more mindfulness.

Time frame: Baseline, Immediate post-intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post-baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsFive-Facet Mindfulness QuestionnaireImmediate follow up19.4 score on a scaleStandard Deviation 2.2
All ParticipantsFive-Facet Mindfulness Questionnaire3 month follow up19.9 score on a scaleStandard Deviation 2.9
BREATHE-T1D Health EducationFive-Facet Mindfulness QuestionnaireImmediate follow up18.5 score on a scaleStandard Deviation 3.3
BREATHE-T1D Health EducationFive-Facet Mindfulness Questionnaire3 month follow up19.1 score on a scaleStandard Deviation 3.7
Secondary

Glycemic Control

HbA1c is a measure of an average blood glucose level over the past 3 months and will be abstracted from the medical record as it is assessed at each regular diabetes clinic visit. HbA1c typically ranges from 4% to \>14%.

Time frame: Baseline, immediate post intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsGlycemic ControlImmediate follow up7.95 percentageStandard Deviation 1.3
All ParticipantsGlycemic Control3 month follow up7.6 percentageStandard Deviation 1
BREATHE-T1D Health EducationGlycemic ControlImmediate follow up8.79 percentageStandard Deviation 2.5
BREATHE-T1D Health EducationGlycemic Control3 month follow up8.7 percentageStandard Deviation 2.6
Secondary

Interventionist Adherence to Session Manuals

Supervisors listened to recordings of sessions for both programs and completed checklists assessing for the number of expected intervention components included in the sessions. Therefore, values reflect the percentage of expected intervention components included across all program sessions calculated at the end of the intervention period (week 6) for each group cohort.

Time frame: Week 6 of intervention

Population: All participants were included as these were ratings of sessions, not individual by participant.

ArmMeasureValue (MEAN)Dispersion
All ParticipantsInterventionist Adherence to Session Manuals100 percentage of intervention componentsStandard Deviation 0
BREATHE-T1D Health EducationInterventionist Adherence to Session Manuals100 percentage of intervention componentsStandard Deviation 0
Secondary

Mindful Attention Awareness Scale

Assessed via teen report. Scores are calculated as an average score of all items with a range of 1 (minimum) to 6 (maximum) with higher scores indicating more mindful attention in daily life.

Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsMindful Attention Awareness ScaleImmediate follow up3.8 score on a scaleStandard Deviation 0.87
All ParticipantsMindful Attention Awareness Scale3 month follow up3.9 score on a scaleStandard Deviation 1.3
BREATHE-T1D Health EducationMindful Attention Awareness ScaleImmediate follow up3.8 score on a scaleStandard Deviation 0.99
BREATHE-T1D Health EducationMindful Attention Awareness Scale3 month follow up3.9 score on a scaleStandard Deviation 1
Secondary

Problem Areas in Diabetes - Teen

The Problem Areas in Diabetes-Teen (PAID-T) is a 14-item measure of diabetes distress in adolescents with type 1 diabetes. Adolescents are asked how often each diabetes-related problem applied to them in the past month, on a six-point Likert scale (ranging from not a problem to serious problem), with scores reflecting a total across 14 items and higher scores indicating greater severity and a clinical cutoff of \>44. Scores can range from 14-84.

Time frame: Baseline, immediate post intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsProblem Areas in Diabetes - TeenImmediate follow up49.8 score on a scaleStandard Deviation 22.4
All ParticipantsProblem Areas in Diabetes - Teen3 month follow up46.8 score on a scaleStandard Deviation 19.4
BREATHE-T1D Health EducationProblem Areas in Diabetes - TeenImmediate follow up53.1 score on a scaleStandard Deviation 22.7
BREATHE-T1D Health EducationProblem Areas in Diabetes - Teen3 month follow up49.1 score on a scaleStandard Deviation 21.1
Secondary

PROMIS Anxiety Short Form - Adolescent Report

Scores are calculated as t-scores (range 0-100) with higher scores indicating more anxiety symptoms.T-scores over 55 indicate clinically significant anxiety symptoms. Interpretation of t-scores is based on a mean of 50 and standard deviation of 10.

Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsPROMIS Anxiety Short Form - Adolescent ReportImmediate follow up56.7 T-scoreStandard Deviation 6.6
All ParticipantsPROMIS Anxiety Short Form - Adolescent Report3 month follow up53.8 T-scoreStandard Deviation 7.6
BREATHE-T1D Health EducationPROMIS Anxiety Short Form - Adolescent ReportImmediate follow up53.8 T-scoreStandard Deviation 8.1
BREATHE-T1D Health EducationPROMIS Anxiety Short Form - Adolescent Report3 month follow up54.0 T-scoreStandard Deviation 8.6
Secondary

PROMIS Depression Short Form - Adolescent Report

Scores are calculated as t-scores with higher scores indicating more depressive symptoms. T-scores (range 0-100) over 55 indicate clinically significant depressive symptoms. Interpretation of t-scores is based on a mean of 50 and standard deviation of 10.

Time frame: Baseline, Immediate post-intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsPROMIS Depression Short Form - Adolescent ReportImmediate follow up55.9 t-scoreStandard Deviation 9.4
All ParticipantsPROMIS Depression Short Form - Adolescent Report3 month follow up53.0 t-scoreStandard Deviation 9.6
BREATHE-T1D Health EducationPROMIS Depression Short Form - Adolescent ReportImmediate follow up54.8 t-scoreStandard Deviation 9.8
BREATHE-T1D Health EducationPROMIS Depression Short Form - Adolescent Report3 month follow up56.0 t-scoreStandard Deviation 9.2
Secondary

Self-Care Inventory

Teen report on the Self-Care Inventory, a measure of diabetes management with higher scores indicating better self-care for diabetes. Average scores range from 1 (minimum) to 5 (maximum).

Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsSelf-Care InventoryImmediate follow up3.73 units on a scaleStandard Deviation 0.66
All ParticipantsSelf-Care Inventory3 month follow up3.68 units on a scaleStandard Deviation 0.71
BREATHE-T1D Health EducationSelf-Care InventoryImmediate follow up3.53 units on a scaleStandard Deviation 0.77
BREATHE-T1D Health EducationSelf-Care Inventory3 month follow up3.48 units on a scaleStandard Deviation 0.76
Secondary

UPPS-P Negative Urgency Subscale

Teen report on the UPPS-P Negative Urgency subscale with higher scores indicating more likelihood to act impulsively when experiencing a negative mood. Scores are calculated with an average which can range from 1(minimum) to 4 (maximum).

Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsUPPS-P Negative Urgency Subscale3 month follow up2.65 score on a scaleStandard Deviation 0.58
All ParticipantsUPPS-P Negative Urgency SubscaleImmediate follow up2.52 score on a scaleStandard Deviation 0.85
BREATHE-T1D Health EducationUPPS-P Negative Urgency SubscaleImmediate follow up2.42 score on a scaleStandard Deviation 0.68
BREATHE-T1D Health EducationUPPS-P Negative Urgency Subscale3 month follow up2.64 score on a scaleStandard Deviation 0.63

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026